Skip to main content
Free research Free research Free assay review with research home and workspace preview
Quick search ChEMBL 36
Assay Detail

CHEMBL3998243

Review assay metadata, readout intent, target linkage, and publication context from the same page.

Binding
Inhibition of VEGFR-2 in human U251 cells assessed as reduction in VEGF induced phosphorylation preincubated for 60 mins followed by VEGF addition measured after 10 mins by ELISA method
12
Total Activities
12
Compounds Tested
1
Activity Types
0
Assay Parameters

Assay Information

Assay Type Binding
Organism Homo sapiens
Confidence 9 — Direct single protein target
Curated By Autocuration

Target

Vascular endothelial growth factor receptor 2 (CHEMBL279)
Type SINGLE PROTEIN
Organism Homo sapiens

Publication

Discovery and preclinical evaluation of 7-benzyl-N-(substituted)-pyrrolo[3,2-d]pyrimidin-4-amines as single agents with microtubule targeting effects along with triple-acting angiokinase inhibition as antitumor agents.
Pavana RK, Choudhary S, Bastian A, Ihnat MA, Bai R, Hamel E, Gangjee A.
Bioorg Med Chem (2017) 25 : 545 -556
PubMed 27894589 · DOI

Activity Statistics

Type Count Avg pChEMBL Best pChEMBL
IC50 12 7.43 7.57

Compounds Tested

Compound Name Phase Activities Best pChEMBL
CHEMBL4099682 1 7.57
CHEMBL4099329 1 7.56
CHEMBL4060996 1 7.48
CHEMBL4104515 1 7.48
CHEMBL4069672 1 7.41
CHEMBL4072383 1 7.07
CHEMBL4098409 1 -
CHEMBL67 COMBRETASTATIN A4 -1.0 1 -
CHEMBL276711 SEMAXANIB 3.0 1 -
CHEMBL535 SUNITINIB 4.0 1 -
CHEMBL553 ERLOTINIB 4.0 1 -
CHEMBL53463 DOXORUBICIN 4.0 1 -

Activity Data

Compound Name Type Rel. Value Units pChEMBL
CHEMBL4099682 IC50 = 26.7 nM 7.57
CHEMBL4099329 IC50 = 27.3 nM 7.56
CHEMBL4060996 IC50 = 33.0 nM 7.48
CHEMBL4104515 IC50 = 32.9 nM 7.48
CHEMBL4069672 IC50 = 38.7 nM 7.41
CHEMBL4072383 IC50 = 84.3 nM 7.07
CHEMBL4098409 IC50 > 200.0 nM -
CHEMBL67 COMBRETASTATIN A4 IC50 - -
CHEMBL276711 SEMAXANIB IC50 = 12.9 nM -
CHEMBL535 SUNITINIB IC50 = 18.9 nM -
CHEMBL553 ERLOTINIB IC50 - -
CHEMBL53463 DOXORUBICIN IC50 - -